Neurosurgery Devices Market By Product (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid (CSF) Management Devices, Others) , By Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neu

Neurosurgery Devices Market By Product (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid (CSF) Management Devices, Others) , By Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neuroendoscopy) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033


The neurosurgery devices market was valued at $11.9 billion in 2023, and is projected to reach $34.5 billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033.

Neurosurgery devices are specialized medical equipment designed for diagnosing, monitoring, and treating disorders within the central and peripheral nervous systems, particularly in surgical procedures involving the brain, spinal cord, and nerves. These devices play a crucial role in managing neurological conditions such as brain tumors, aneurysms, traumatic brain injuries, and spinal cord injuries.

Alarming rise in prevalence of neurological disorders such as brain tumors, epilepsy, Parkinson’s disease, and spinal cord injuries and surge in need for advanced surgical tools act as the key driving forces of the global neurosurgery devices market. A 2024 study published by the World Health Organization reported that more than 3 billion worldwide are suffering from neurological condition. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that as people age, neurons in the brain and nervous system can gradually deteriorate and lose functionality, and thus they become more susceptible to age-related neurological disorders such as Alzheimer’s and Parkinson’s. . As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, improvement in healthcare infrastructure, increase in investments in medical technology, and higher availability of neurosurgical facilities are the key factors supporting the global market growth. Furthermore, increase in funding for neurological research and healthcare subsidies are aiding in the development and adoption of neurosurgery devices, thereby augmenting the market growth. However, high cost associated with advanced neurosurgery devices, such as robotic surgical systems, imaging equipment, and high-precision tools, restrains the market growth. In addition, dearth of skilled neurosurgeons to operate advanced devices acts as the key deterrent factor of the market. On the contrary, innovations in imaging, robotic assistance, and minimally invasive techniques are enhancing the precision, safety, and efficiency of neurosurgical procedures. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global neurosurgery devices industry is segmented into product, application, end user, and region. By product, the market is classified into neurostimulation devices, neurointerventional devices, neurosurgical navigation systems, cerebral spinal fluid (CSF) management devices, and others. On the basis of application, it is segregated into spinal cord stimulation, deep brain stimulation, and neuroendoscopy. Depending on end user, it is fragmented into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the neurostimulation devices segment held the market share in 2023.

On the basis of application, the deep brain stimulation segment dominated the market, in terms of share, in 2023.

Depending on end user, the hospital segment was the major shareholder in 2023.

Region wise, North America emerged as the most lucrative market for neurosurgery devices in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global neurosurgery devices market include Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Johnson and Johnson, Integra Lifesciences Corporation., Medtronic Plc, and Stryker Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Key Market Segments

By Product

Neurostimulation Devices
Neurointerventional Devices
Neurosurgical Navigation Systems
Cerebral Spinal Fluid (CSF) Management Devices
Others

By Application

Spinal Cord Stimulation
Deep Brain Stimulation
Neuroendoscopy

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Abbott Laboratories
Ackermann Instrumente GmbH
Adeor Medical AG
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corporation
Johnson and Johnson
Integra Lifesciences Corporation.
Medtronic plc
Stryker Corporation.


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: NEUROSURGERY DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Neurostimulation Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Neurointerventional Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Neurosurgical Navigation Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Cerebral Spinal Fluid (CSF) Management Devices
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: NEUROSURGERY DEVICES MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Spinal Cord Stimulation
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Deep Brain Stimulation
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Neuroendoscopy
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: NEUROSURGERY DEVICES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: NEUROSURGERY DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Neurosurgery Devices Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Neurosurgery Devices Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Neurosurgery Devices Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Neurosurgery Devices Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Neurosurgery Devices Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Neurosurgery Devices Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Neurosurgery Devices Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Neurosurgery Devices Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Neurosurgery Devices Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Neurosurgery Devices Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Neurosurgery Devices Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Neurosurgery Devices Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Neurosurgery Devices Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Neurosurgery Devices Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Neurosurgery Devices Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Neurosurgery Devices Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Neurosurgery Devices Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Neurosurgery Devices Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Neurosurgery Devices Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Ackermann Instrumente GmbH
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Adeor Medical AG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. B. Braun Melsungen AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Biotronik SE And Co. KG
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Boston Scientific Corporation
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Johnson And Johnson
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Integra Lifesciences Corporation.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Medtronic Plc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Stryker Corporation.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 8. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 12. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. NEUROSURGERY DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 18. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. U.S. NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 21. U.S. NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. U.S. NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. CANADA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 24. CANADA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. CANADA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 27. MEXICO NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 28. MEXICO NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 31. EUROPE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. EUROPE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. FRANCE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 37. FRANCE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. FRANCE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. UK NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 40. UK NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. UK NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. ITALY NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 43. ITALY NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. ITALY NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. SPAIN NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. SPAIN NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. SPAIN NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 49. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 50. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 53. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. CHINA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. CHINA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. CHINA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 62. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. INDIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 65. INDIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. INDIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 68. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 71. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 72. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. LAMEA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. LAMEA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 78. BRAZIL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. BRAZIL NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 84. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 87. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 88. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 89. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 90. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 91. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 92. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 93. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. ACKERMANN INSTRUMENTE GMBH: KEY EXECUTIVES
TABLE 95. ACKERMANN INSTRUMENTE GMBH: COMPANY SNAPSHOT
TABLE 96. ACKERMANN INSTRUMENTE GMBH: OPERATING SEGMENTS
TABLE 97. ACKERMANN INSTRUMENTE GMBH: PRODUCT PORTFOLIO
TABLE 98. ACKERMANN INSTRUMENTE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. ADEOR MEDICAL AG: KEY EXECUTIVES
TABLE 100. ADEOR MEDICAL AG: COMPANY SNAPSHOT
TABLE 101. ADEOR MEDICAL AG: OPERATING SEGMENTS
TABLE 102. ADEOR MEDICAL AG: PRODUCT PORTFOLIO
TABLE 103. ADEOR MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 105. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 106. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 107. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 108. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
TABLE 110. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 111. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
TABLE 112. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 113. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 115. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 116. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 117. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 118. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 120. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 121. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 122. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 123. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. INTEGRA LIFESCIENCES CORPORATION.: KEY EXECUTIVES
TABLE 125. INTEGRA LIFESCIENCES CORPORATION.: COMPANY SNAPSHOT
TABLE 126. INTEGRA LIFESCIENCES CORPORATION.: OPERATING SEGMENTS
TABLE 127. INTEGRA LIFESCIENCES CORPORATION.: PRODUCT PORTFOLIO
TABLE 128. INTEGRA LIFESCIENCES CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 130. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 131. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 132. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 133. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134. STRYKER CORPORATION.: KEY EXECUTIVES
TABLE 135. STRYKER CORPORATION.: COMPANY SNAPSHOT
TABLE 136. STRYKER CORPORATION.: OPERATING SEGMENTS
TABLE 137. STRYKER CORPORATION.: PRODUCT PORTFOLIO
TABLE 138. STRYKER CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF NEUROSURGERY DEVICES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN NEUROSURGERY DEVICES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROSURGERY DEVICES MARKET
FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY APPLICATION
FIGURE 17. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY END USER
FIGURE 21. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 28. COMPETITIVE DASHBOARD
FIGURE 29. COMPETITIVE HEATMAP: NEUROSURGERY DEVICES MARKET
FIGURE 30. TOP PLAYER POSITIONING, 2023
FIGURE 31. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. ACKERMANN INSTRUMENTE GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. ADEOR MEDICAL AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. ADEOR MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. ADEOR MEDICAL AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. BIOTRONIK SE AND CO. KG: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. INTEGRA LIFESCIENCES CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 58. STRYKER CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 59. STRYKER CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 60. STRYKER CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings